Related Experiment Videos

Optimal treatment of acute coronary syndromes--an evolving strategy

W E Boden, R G McKay

The New England Journal of Medicine

|June 23, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

State of the art approach to managing angina and ischemia: tailoring treatment to the evidence.

European journal of internal medicine·2021

Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.

Herz·2013

Interpretation of new treatment guidelines for non-ST-segment elevation acute coronary syndromes: "ischemia-guided" versus "early invasive" strategies.

Minerva cardioangiologica·2003

Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction.

The American journal of cardiology·2002

Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non-ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials.

Current opinion in cardiology·2001

Defining the optimal pharmacotherapy of non-ST-segment elevation (NSTE) acute coronary syndromes (ACS): a rapidly moving target.

Current opinion in cardiology·2001

See all related articles